FINN Partners Named Agency of Record for AD/PD - Advances in Science & Therapy 2027

FINN Partners has been appointed Agency of Record for AD/PD - Advances in Science & Therapy 2027. The news surfaced via a LinkedIn post from Jessica Hoffman on September 15, 2026.

AD/PD - Advances in Science & Therapy is an international scientific conference focused on Alzheimer's and Parkinson's disease research. Under the new assignment, FINN Partners will lead public relations and marketing efforts for the 2027 edition of the event.

Financial terms of the FINN Partners AD/PD Advances in Science & Therapy engagement have not been disclosed. No details on campaign scope, budget, or duration were included in the announcement. The announcement did not specify whether the appointment followed a competitive review or was awarded directly.

FINN Partners is a global public relations and marketing firm with offices across North America, Europe, and Asia. The agency's client roster spans health care, life sciences, and technology, including work in medical and scientific communications.

The AD/PD Advances in Science conference draws researchers, clinicians, and industry stakeholders working on neurodegenerative disease. FINN Partners will handle public-facing communications for the 2027 gathering. Specific deliverables have not been outlined.

This marks FINN Partners' entry as Agency of Record for the AD/PD - Advances in Science & Therapy conference series, according to the LinkedIn announcement. No additional agencies were named in connection with the account.